Phase 3 Study of ASP1941 - A Long-term Administration Study in Subjects With Type 2 Diabetes Mellitus (T2DM)
Phase of Trial: Phase III
Latest Information Update: 24 Apr 2013
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Oct 2012 Planned End Date changed from 1 Jun 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.